GLP-3 (LY3437943) is a novel investigational peptide compound developed for in-vitro and preclinical research applications. It is a synthetic analog targeting three receptor pathways glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors making it a subject of significant academic interest in metabolic research models. Helix Strand Labs supplies GLP-3 exclusively for research and laboratory use. This compound has not received FDA approval for any therapeutic application and is not approved for human administration.
Molecular Weight: ~4.8 kDa
Purity: ≥98% (HPLC verified)
Sequence: Available upon request with COA
Storage & Stability: Lyophilized powder. Store at -20°C. Stable 24 months sealed. After reconstitution, refrigerate at 2–8°C and use within 28 days.


